$150K — $200K *
Annexon Biosciences is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. The Company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. The Company’s first product candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. The Company’s second product candidate, ANX007, is a monoclonal antibody antigen-binding fragment (Fab) formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. Based on learnings from its initial trials, Annexon is advancing its current programs while evaluating additional orphan and large market indications. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish that each of its product candidates is engaging the specific target at a well-tolerated therapeutic dose in the intended patient tissue.
Annexon is looking for an energetic and talented individual to join its lean legal team. Reporting to the VP, Legal and IP, the successful candidate will interact with all levels of the organization including executive management and be a crucial part of building out the legal infrastructure of a growing company, with an initial focus on the contracts function. The candidate will be expected to take the knowledge they have amassed at a national law firm and/ or in-house life sciences experience and apply it appropriately to a growth-stage company. The successful candidate will have significant experience handling the variety of contracts necessary for the startup and conduct of global clinical trials, and a willingness to expand into other substantive areas to support business needs.
Clinical and Manufacturing Contracts
Valid through: 3/29/2021